Real-World First-Line Serplulimab-Based Immunochemotherapy for Extensive-Stage Small Cell Lung Cancer: The Multicenter ASTRUM-005R Study

被引：0
|
作者：
Wu, L. [1 ]
Hu, C. [2 ]
Su, W. [3 ]
Yu, Y. [4 ]
Hong, W. [5 ]
Liu, Z. [6 ,8 ]
Su, H. [7 ]
Liu, Z. [6 ,8 ]
Wang, C. [9 ]
Pu, Q. [10 ]
Guo, H. [11 ]
Min, X. [12 ]
Chen, Y. [3 ]
Zhu, H. [13 ]
Luo, T. [14 ]
机构：
[1] Hunan Canc Hosp, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China
[3] Chinese Acad Med Sci, Canc Hosp, Shanxi Hosp, Taiyuan, Peoples R China
[4] Harbin Med Univ Canc Hosp, Harbin, Peoples R China
[5] Univ Chinese Acad Sci, Dept Chest Oncol, Canc Hosp, Beijing, Peoples R China
[6] Southern Med Univ, Affiliated Hosp 10, Dongguan Peoples Hosp, Dongguan, Peoples R China
[7] Air Force Med Univ, Xian, Peoples R China
[8] Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China
[9] Shandong First Med Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
[10] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China
[11] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China
[12] AN HUI CHEST Hosp, Hefei, Anhui, Peoples R China
[13] Shandong First Med Univ, Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[14] Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Extensive-stage small cell lung cancer; PD-1; inhibitor; Serplulimab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.13A.07
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [41] A comparative study on etoposide combined with lobaplatin or cisplatin in the first-line treatment of extensive-stage small cell lung cancer
    Li, Shujun
    Liang, Yahai
    Wu, Yanxia
    Huang, Zhong
    Lin, Yanming
    Yang, Zhixiong
    Chen, Hualin
    Wu, Aibing
    JOURNAL OF BUON, 2020, 25 (03): : 1490 - 1496
  • [42] Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practice
    Yang, Yaning
    Ai, Xin
    Xu, Haiyan
    Yang, Guangjian
    Yang, Lu
    Hao, Xuezhi
    Yang, Ke
    Mi, Yuling
    Wang, Guizhen
    Zhang, Shuyang
    Lei, Siyu
    Wang, Yan
    THORACIC CANCER, 2022, 13 (23) : 3295 - 3303
  • [43] IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer
    Huang, Chengliang
    Gan, Gregory N.
    Zhang, Jun
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [44] Anlotinib Plus Standard Chemotherapy as First-line Treatment in Extensive-Stage Small Cell Lung Cancer Patients
    Zhang, W.
    Yang, H.
    Kong, T.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S536 - S536
  • [45] Clinical efficacy of Camrelizumab combined with first-line chemotherapy in extensive-stage small-cell lung cancer
    Zhang, Dou
    Kong, Fanming
    Gao, Fangfang
    Li, Longhui
    Liang, Yangyueying
    Yu, Minghui
    Zhao, Lu
    Wang, Na
    Jia, Yingjie
    HELIYON, 2024, 10 (01)
  • [46] Anlotinib plus standard chemotherapy as first-line treatment in extensive-stage small cell lung cancer patients
    Zhang, W.
    Yang, H.
    Kong, T.
    Han, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S1580 - S1580
  • [47] Prognostic implications of neutrophil-to-lymphocyte ratio in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real-world study
    Bi, Huanhuan
    Ren, Dunqiang
    Xiao, Yuting
    Zhou, Yinxue
    Yi, Bingqian
    Han, Weizhong
    Shao, Yanmei
    Wang, Jingluan
    Zhang, Chunling
    Wang, Hongmei
    THORACIC CANCER, 2024, 15 (07) : 559 - 569
  • [48] Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
    Xiang, Y.
    Tang, Y.
    Luan, T.
    Mengchen, L.
    Shi, W.
    Chin, A. G. W.
    Feng, X.
    Wang, F.
    Sun, X. W.
    Bao, Z.
    Zhou, J.
    Zhao, J.
    Wu, H.
    Fu, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S1666 - S1667
  • [49] IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer
    Chengliang Huang
    Gregory N. Gan
    Jun Zhang
    Journal of Hematology & Oncology, 13
  • [50] Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
    Goldschmidt, Jerome
    Hart, Lowell
    Scott, Jeffrey
    Boykin, Kristen
    Bailey, Ray
    Heritage, Trevor
    Lopez-Gonzalez, Lorena
    Zhou, Zheng-Yi
    Edwards, Marie Louise
    Monnette, Alisha
    Ogbonnaya, Augustina
    Deyoung, Kathryn
    Venkatasetty, Divea
    Shi, Ping
    Aton, Lindsay
    Huang, Huan
    Conkling, Paul. R. R.
    Gordan, Lucio
    ADVANCES IN THERAPY, 2023, 40 (10) : 4189 - 4215
12345